Bringing you the latest research in Drug Discovery In New Modalities, Integration Of DEL, Covalent Inhibitors, Protein Degradation Technologies, Computational Drug Design & Automation Strategies and more, through a range of Speaker Interviews, Industry Insights, and Expert Opinions.
Talking with Nicolas Vachicouras, CEO of Neurosoft Bioelectronics about their subdural brain interface and its inaugural clinical testing for recording the human brain in the context of an epilepsy resective surgery.
Positive phase III results propel innovative pherine nasal spray as potential game-changer for millions struggling with social anxiety disorder. Vistagen's novel mechanism of action sparks optimism after previous setback.
Significant findings after the Schedule I controlled drug completes Phase III clinical trial for PTSD patients.
Edited by Tom Cohen |
19 January 2023
Search by Keyword
Filter by Subject Area
Filter by Content Type
We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.